A 66-year-old woman who was positive for human T-lymphotropic 
Introduction

Mixed connective tissue disease (MCTD) is considered to be one of the autoimmune inflammatory diseases related to human T lymphotropic virus type I (HTLV-I) infection (1-4). Although cytotoxic T lymphocytes (CTL) against HTLV-I related antigens may be implicated in the destruction of host tissue in HTLV-I-related MCTD
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On the other hand, HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell leukemia/lymphoma (ATLL) are the representative diseases caused by HTLV-I infection (7). Although there is no definitive evidence, from the viewpoint of host defense towards HTLV-I, HAM/TSP is considered to be a spinal tissue damage triggered by exaggerated T-cell responses to HTLV-I (8, 9), while ATLL is considered to be a consequent lymphoid malignancy partially due to the deterioration of CTL functions against transformed T-cells bearing monoclonal integration of HTLV-I provirus
We report a 66-year-old woman with HTLV-I-related
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g/dl of hemoglobin), a highly elevated level of LDH (10544 IU/l), and elevated levels of Ca (13.4 mg/dl), AST (113 IU/l), and CRP (0.7 mg/dl). Both titers of TK and sIL2R were extremely high, with 510 U/l for TK and 162000 U/ml for sIL2R. Finally the monoclonal integration of HTLV-I provirus was confirmed by southern blotting
Discussion
HTLV-I infection has been reported to be implicated in several inflammatory disorders, such as arthritis, polymyositis, uveitis, Sjögren's syndrome, alveolitis and so on, while the actual relative risk of HTLV-I infection for each inflammatory disease has not been documented yet, due to the lack of epidemiologically large-scale surveys (19). MCTD is also an HTLV-I infection-related inflammatory disease, but it's clinical aspects and etiology have not been fully described yet. In Table 2, five reported cases (including our case) are summarized (1-4). All are female patients of various ages, all but our case are younger than 60 years, an age which is susceptible to ATLL, and two cases are complicated with interstitial pneumonia (IP). At the diagnosis of MCTD, only one case had 5% of atypical lymphocytes in the periphery. Four of 5 cases received corticosteroid and the manifestations of MCTD declined, however no description about the development of ATLL was documented. Although the precise mechanism of HTLV-I-related MCTD
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still remains unclear, two possible explanations are proposed. One is the probable molecular mimicry (crossreactivity) between HTLV-I and U1-ribonucleoprotein (RNP) assumed by the homologous amino acid sequence between U1-RNP and retroviral p30 gag protein (6), and the other is that humoral and cellular immune responses against HTLV-I LTR-env-pX related antigens may mutually render hosts hypersensitive to various immunological stimulations and that excessively robust immune responses may result in the destruction of host tissues (5). The mutual interactions between the autoimmunity which may cause HTLV-I-related inflammatory diseases and the anti-tumor immunity against ATLL in HTLV-I carriers still remains unsolved. HAM/TSP is one of the representative diseases caused by HTLV-I infection (7), and is defined as a consequent neural damage attacked by CTL principally harnessed to HTLV-I. This concept is supported by the frequent detection of the HTLV-I Tax-derived peptide-specific CTL in the periphery by tetramer assay among patients with HAM/TSP
